PacBio (PACB) reported second-quarter 2026 revenue of $39.0 million, compared with $39.8 million a year earlier. GAAP net loss was $44.7 million, compared with $41.9 million in the second quarter of 2025.
The company reported GAAP net loss per share of $0.14, unchanged from the year-earlier period. PacBio also said it expects full-year 2026 revenue of $155 million to $165 million.
- Total revenue was $39.0 million, including $20.1 million in consumables revenue, $12.8 million in instrument revenue and $6.1 million in service and other revenue.
- PacBio placed 20 Revio systems and 26 Vega systems during the quarter.
- Ending cash, cash equivalents and investments were $236.9 million.
- GAAP gross profit was $12.6 million, with GAAP gross margin of 32%.
- GAAP operating expenses totaled $57.2 million.
- The company began the global commercial rollout of SPRQ-Nx chemistry.
$PACB Insider Trading Activity
$PACB insiders have traded $PACB stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $PACB stock by insiders over the last 6 months:
- CHRISTIAN O HENRY (See Remarks) has made 0 purchases and 3 sales selling 485,164 shares for an estimated $771,309.
- OENE MARK VAN (See Remarks) has made 0 purchases and 3 sales selling 191,401 shares for an estimated $304,165.
- JAMES R II GIBSON (See Remarks) sold 88,185 shares for an estimated $120,813
- MICHELE FARMER (See Remarks) has made 0 purchases and 3 sales selling 53,146 shares for an estimated $84,365.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PACB Hedge Fund Activity
We have seen 87 institutional investors add shares of $PACB stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CASDIN CAPITAL, LLC removed 3,500,000 shares (-82.9%) from their portfolio in Q1 2026, for an estimated $4,620,000
- AMIRAL GESTION removed 2,733,290 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,607,942
- POINT72 ASSET MANAGEMENT, L.P. removed 2,671,700 shares (-90.3%) from their portfolio in Q1 2026, for an estimated $3,526,644
- KOSS-OLINGER CONSULTING, LLC removed 2,600,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,432,000
- NUVEEN, LLC added 2,102,710 shares (+247.9%) to their portfolio in Q1 2026, for an estimated $2,775,577
- BLACKROCK, INC. added 1,922,459 shares (+8.2%) to their portfolio in Q1 2026, for an estimated $2,537,645
- CITADEL ADVISORS LLC removed 1,590,190 shares (-50.2%) from their portfolio in Q1 2026, for an estimated $2,099,050
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
